高鍶礦泉水研究簡(jiǎn)報(bào)_第1頁(yè)
高鍶礦泉水研究簡(jiǎn)報(bào)_第2頁(yè)
高鍶礦泉水研究簡(jiǎn)報(bào)_第3頁(yè)
高鍶礦泉水研究簡(jiǎn)報(bào)_第4頁(yè)
高鍶礦泉水研究簡(jiǎn)報(bào)_第5頁(yè)
已閱讀5頁(yè),還剩16頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

瀘云礦水限司研簡(jiǎn)一長(zhǎng)江雪嶺鍶礦泉水對(duì)養(yǎng)人肝細(xì)胞增及功能的影目胞LO2增殖和方:LO2MTT法檢測(cè)其增殖活力,并測(cè)定培養(yǎng)上清液中AST、ALT的代于96孔板每孔的細(xì)胞×10

/ml、4mg/L、6mg/L含含鍶的2mg/L、4mg/L組、6mg/L組和8mg/L組2天、天和用MTT并在第4天取培定AST及結(jié):胞3天后2mg/L4mg/L6mg/L8mg/L組肝細(xì)接種5天與空白組相

中4mg/L和6mg/L組種7天后6mg/L差異中AST及ALT異具、2mg/L及6mg/L組AST及ALT酶2mg/L與空白組比較對(duì)照、、6mg/L組培養(yǎng)差異具顯著性中6mg/L組總膽紅在一定濃鍶礦低ASTALT酶年10月18日/p>

瀘云礦水限司研簡(jiǎn)二長(zhǎng)江雪嶺鍶礦泉水對(duì)Wistar大鼠Ⅰ型糖尿的影響可現(xiàn)代科學(xué)已證實(shí)糖尿病與人(strontium,Sr)39微克,成年人鍶2鍶與疾病高鍶wistar大鼠I型≥目:對(duì)I型糖尿病大鼠的血糖方:克,雄雌各半,一次性(STZ)60復(fù)制I型糖尿病模型3天

達(dá)(DM鼠DM鼠隨機(jī)Sr2mg/L(組)、Sr4mg/L(B組)組Sr6mg/L長(zhǎng)C長(zhǎng)組DM組(N=32)DM組分別于第12個(gè)月、第34個(gè)月隨機(jī)處死游離結(jié):(GLu血乳酸(LD第1、2、3、4,、、C、D與DM組(P>0.05白GHb)1月,B、組糖化血紅蛋白較DM(2、、4月,A、、C、D組(NEFA1、月,、、C、D組均較組明顯(3、月,D組較(1月組均較DM組明顯P<0.05D(P<0.012月,DM組明顯(3、月A、、、與DM

醇1月,、、、與DM第2,組DM34A組DM組比較結(jié):在型糖油對(duì)型糖I病年10月18/p>

瀘云礦水限司研簡(jiǎn)三不同濃度長(zhǎng)江雪嶺高礦泉水對(duì)HK-2細(xì)胞增殖及的影響背目前定范圍內(nèi)高濃度的鍶對(duì)人體健康是目:HK-2人其方代于96孔板為5×104/ml8h含鍶礦泉水、6mg/L含的DMEM培養(yǎng)2mg組組、37℃、296h和育4h,出現(xiàn)溶解液100ul,置于長(zhǎng)570nm處讀取OD.根據(jù)吸光值并65×4/ml24h

8個(gè)復(fù)孔。-20融次,刮刀收集測(cè)ATP酶活性。果:和6mg/L濃度的含細(xì)胞的增(p<0.05濃力P<0.05)。4mg/L6mg/L能年10月18日/p>

瀘云礦水限司研簡(jiǎn)四長(zhǎng)江雪嶺鍶礦泉水對(duì)尿酸血癥(痛風(fēng))大鼠的影響strontium,,成年目方:年Wistar大鼠200只200206克克體第0第20顯示隨后+

為的+飲水、高尿酸血癥模型組

單獨(dú)飲水組別嘌呤醇+飲水組

自來(lái)水組4mg/L鍶礦泉水組6mg/L鍶礦泉水組8mg/L鍶礦泉水組別嘌呤醇治療自來(lái)水組別嘌呤醇治療+鍶礦泉水組別嘌呤醇治療+鍶礦泉水組別嘌呤醇治療+鍶礦泉水組醇100mg/kg灌喂組第1246周8取8血肌處死結(jié):1P<0.05+各高鍶礦泉水組與別嘌呤治療+(P(P>0.052療+各高療尿(P>0.05嘌呤治+療+P<0.05

療后療后周別療療4mg/L鍶P療第周。江雪含為的高測(cè)病理生理學(xué)教研室年10月16日/p>

TheBrief1TheEffectofChangJiangMountainsHighConcentrationMineralOnLiverLO2Proliferationand:TotheofdifferentonhepatocytesproliferationandPreparedculturemediumswaterscontainingandcellstheCellproliferationwasanalyzedbyMTTassay;ASTandALTactivitycontentoftotalbytestkitTheproliferationofCellshowedsignificantdifferences3ineachgroup.thetheofwater,2mg/Land4mg/LgroupcanenhanceproliferationofLO2cellsignificantly,comparedthe,proliferationof6mg/Lgroupnodifference,andlag;Atdaysthetheandeachofthedifferentofstrontium-containingstimulatethecellproliferation,4mg/L6mg/Lcomparedaredifference.At7daysinadditionthethegroupsshowncertaindegreeofinhibition,proliferationof4mg/Land6mg/Lstillbettergroups,but8mg/Lgroupshowed

inhibition.ComparedwiththetheASTandALTactivityofcontrolgroupandwerelower,butthenon-significantbetweenthecontrol2mg/L,4mg/L6mg/LASTandALTactivity8mg/Lwasgroups.totalcontentof2mg/Lhigherthantheothergroupssignificantly;theblankthecontrol4mg/L6mg/Lgroupand8mg/Lgrouptotalwere6mg/Lminimum.Inarangeofconcentration,enhanceculturedcell(LO2)proliferation;canandALTactivityreduceandenhancetheofstrontium;humancellproliferation;ALT;AST;totalbilirubin.ofLuZhoumedical18.Oct.2011

TheBrief2oftheChangJiangSnowyMineralWaterwithConcentrationonTypeIModelsoftraceandtheofbodythefieldsinternationalscientificSomearerelatedtoandconditionofglucoseintheconfirmed,thelackofbodyessentialtracesuchchromium,selenium.that,belongsthemetal,andisalsoakindoftraceelementhumanbody.contentofSr39ug/Lintheblood,andThereislittlestudyabouttheofSrandlittlereportabouttheEffectoftheonstudywastodiscusstheofChangMountainsWaterHighConcentration(cantheevidencetherelationshipSrandTotheofChangMountainsdifferentofoncontentbloodglucose,bloodlactictriglycerides,fattyinI’220~250g,halfmalehalf

theexperiment.injectionofStreptozotocin(STZ)60mg/kgwasdayslater,thefastingglucosethediabetes(DMThenDMrandomlydividedA,ratsdrinkingChangMountainsWaterConcentrationSr2mg/LratsdrinkingChangMoutains4mg/L;groupC,drinkingSnowyMoutanisnaturalSr6mg/L;groupD,ratsdrinkingChangMoutainsnaturalmineral8mg/LDMratsdringkingwater,ratsineachgroup(N=32).ineachgroupaftermonth,thesecondthethirdmonths,andfourthmonthwererandomlyandbloodcollected.Thenthebloodofbloodglycosylatedtriglycerides,fattyinsulin.Therenodifferencethecontentofbloodglocoseacid(LD),insulinbetweenA,B,andDMatend1,2,mo.(>(GHb):Attheof1theofglycatedhemoglo-bingroupDMgroup(PAtthe3,mo,theredifferenceA,C,groupandDMFreefattyacid:Attheend1,2ofNEFAinA,B,wereobviouslythanDMgroup(<Attheendof3mo,theofNEFAinthanDM(<0.05).Triglycerides(TG):Atendof1mo,ofTGinwereobviouslydecreasedcomparedtoDM(PespeciallyingroupD(<Attheendofmo,theof

inthanDMgroup<Attheend3,4therenobetweenA,C,andDM(TC):Atendof1theresignificantbetweenA,B,C,DandDMAtcontentofTCinthanDM(P<0.05);Attheof3andmo,therewasnobetweenB,C,andDMMountainsHighConcentrationansignificantreducingblood-lipoidsIdiabetestheearlystage,obviouslyofnon-esterifiedfattyMountainsHighConcentrationnoofreducingglycatedImellitusMountainsConcentrationnotheofIofPathophysiologymedicalcollege18.Oct.2011

TheBrief3TheEffectofChangJiangMountainsMineralWaterConcentrationonHK-2CellsProliferationandtheActivityofATPEnzymeBackground:Alevelstrontiumtheofhumanbeing,however,notreporteffectstrontiumtheeffectofwaterscontainingdifferentstrontiumcellproliferationandATPenzymeactivity.Preparedthemediumswaterscontainingdifferentculturedcellsthem.CellproliferationbyMTTassay,ATPactivitywasbyATPHK-2cellioncycleprolongedbythestrontiumwaters4mg/Landsixmg/LSrsignificantly,theprosperousproliferationbemorelongerthanblanket<0.05);Strontiumwater2-8mg/LSrcanenhancecellsATPenzymeactivity(p0.05).mineralwater4mg/LSrgood

ofLuZhoumedical18.Oct.2011

TheBriefReport4TheEffectsofChangjiangSnowyMountainsStrontiumhyperuricemiaHyperuricemiaisadiseasehazardstohealthseriously.showntraceelementsrelateddiseases,asdiabetes.(Sr)akindessentialbody.Normalcontent39ug/Linblood.AneedsmgSreveryonrelationshipSrandisalittle,theConcentrationonhyperuricemianotresearchratstohyperuricemiaordertostudytheofChangjiangMountainsStrontiumohyperuricemia(gout).Itwillexperimentalto(gout).TotheofMountainsConcentrationStrontiumonhyperuricemia(gout)throughbloodnitrogenuricacid.Methods:adult±wererandomly

intohyperuricemiagroup.Thehyperuricemiagroupgivenmixturewithyeastaof6g/100gbodydays.groupwerefedratequivalently.Inthe10and20bloodinweretoacidlevel.20daysuricofmixedfedwerehigherthanthatintheitshowedhyperuricemiamodelweresuccessfully.Thenratsinhyperuricemiagrouprandomlydividedintodrinkinggroupand+groupincludedstrontiumquantitymg/L,mg/L,groupandtapAstableinallopurinol+drinkinggroupwerefed100mg/kgbodyweight.Allfednormalfodder.ratswerethe2weeks,weeks.SerumureanitrogenbloodandxanthineoxidasewereandwereassessedbyTable:groupwererandomlyintogroup

tapwatergroupDrinking4mg/LSrmineralgroupwatergroup6mg/LSrmineralgroup8mg/LSrmineralgroupAllopurinolallopurinolgroup

drinkingwatergroup

SrmineralgroupSrmineralgroupSrmineralgroup(1)1uricofdrinkingmineralStrontiumgroupswere<0.05)thantapuricofallopurinol+drinkingConcentration(p<allopurinol+drinkingtapcreatinine,andnitrogeneachno(2)2treatment,drinkingwaterno(P>0.05);uricacidofallopurinol+drinkinggroups

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論